Content overview

9 June 2026

Clarke’s Analysis of Drugs and Poisons

This update contains 2 major revisions to monographs and 1 revision to a chapter.

This update contains:

• 2 fully revised NPS monographs
• 2 Minor updates (corrections and ad hoc)
• Updated prelims

9 June 2026

Pharmaceutical Excipients

This update contains 5 updated monographs. Pharmacopoeias have been globally updated.

Selective Revisions: Anhydrous silicon dioxide; Hypromellose; Lactose monohydrate; Polyethylene glycol; Povidone.

9 June 2026

Martindale’s ADR Checker

This update contains 6 new drugs, 20 minor updates, 13 new or updated pieces of short management advice, and 2 existing drugs have been revalidated.

9 June 2026

Drug Monitoring Checker

This update contains one new monograph.

New monograph: Dulaglutide.

9 June 2026

Critical Illness

This update contains 1 new monograph and 6 minor updates.

New monographs: Pregabalin.

Minor updates: Abbreviations, About Critical Illness, Anidulafungin, Apixaban, Argatroban, Editorial team, and acknowledgements

9 June 2026

BNF for Children

This update contains 4 significant changes, 3 dose changes, 1 classification change, 1 new monograph, and 2 new preparations.

Significant Changes:

• Helminth infections: updated guidance for roundworm and hookworm infections.
• Hepatitis B vaccine: updated guidance for post-exposure prophylaxis of neonates.
• Levamisole: indications and dosing for roundworm infections and hookworm infections removed, and important safety information updated.
• Sepsis: updated guidance on intravenous fluids and vasopressors.

Dose Changes:

• Dexamethasone [new indication and dose for congenital adrenal hyperplasia replaces previous indication and dose for physiological replacement].
• Fludrocortisone acetate [new indications for primary adrenal insufficiency and congenital adrenal hyperplasia replace previous indication for mineralocorticoid replacement in adrenocortical insufficiency; updates to structure of dosing].
• Prednisolone [new indications and doses for adrenal insufficiency and congenital adrenal hyperplasia replace previous indication and dose for corticosteroid replacement therapy].

Classification Changes:

• Levamisole [primary classification changed to Immunosuppressants].

New Monographs:

• Nulibry® [fosdenopterin].

New Preparations: EURneffy® [adrenaline]; Fludrocortisone acetate 0.1 mg/mL oral solution.